FDA Wants Stronger Cardiovascular Warning For OTC NSAIDs
This article was originally published in The Tan Sheet
Executive Summary
The agency says it will require stronger warnings about cardiovascular risks on prescription NSAIDS’ Drug Facts labels, but will request that OTC NSAID labels also are changed.